You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glipizide

Showing 1 - 25 of 56
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human Gastrointestinal Physiology Data Trial in Ann Arbor (Glucotrol XL 5Mg Extended-Release Tablet, Glipizide ER 5 MG 24 HR

Recruiting
  • Human Gastrointestinal Physiology Data
  • Glucotrol XL 5Mg Extended-Release Tablet
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan
Mar 19, 2022

Comparison of Type 2 Diabetes Pharmacotherapy Regimens

Recruiting
  • Type 2 Diabetes Mellitus
  • Cardiovascular Diseases
  • Oakland, California
  • +5 more
Oct 18, 2022

Four Second Line Pharmacological Strategies in Type 2 Diabetes

Active, not recruiting
  • Cardiovascular Events
  • +2 more
  • SGLT2 inhibitor
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 17, 2022

Maturity-Onset Diabetes of the Young, Type 3, Maturity Onset Diabetes of the Young, Type 1, Childhood Diabetes Trial in Bergen

Unknown status
  • Maturity-Onset Diabetes of the Young, Type 3
  • +3 more
  • Bergen, Norway
    Department of Pediatrics and Adolescents, Haukeland University H
Jan 21, 2020

Diabetes, Dementia, Hypoglycemia; Drug Trial (STRIDE)

Not yet recruiting
  • Diabetes
  • +2 more
  • STRIDE
  • (no location specified)
Sep 6, 2022

Second Line Therapy Medications in Diabetes

Recruiting
  • Diabetes Mellitus, Type 2
  • Wilmington, Delaware
  • +4 more
Dec 22, 2021

Abdominal Obesity, Type 2 Diabetes Trial in San Luis Potosi (Biguanide, DPP4 inhibitors, SGLT2 inhibitors)

Enrolling by invitation
  • Abdominal Obesity
  • Type 2 Diabetes
  • Biguanide, DPP4 inhibitors, SGLT2 inhibitors
  • San Luis Potosi, Mexico
    Metabolic Research Unit
Sep 1, 2021

Chronic Kidney Diseases, Type 2 Diabetes Trial in Seattle (Linagliptin, Glipizide)

Completed
Has Results
  • Chronic Kidney Diseases
  • Type 2 Diabetes
  • Seattle, Washington
    University of Washington
Sep 12, 2018

Acne Vulgaris Trial in Davis, Sacramento (Tretinoin, Isotretinoin)

Completed
  • Acne Vulgaris
  • Davis, California
  • +1 more
Aug 4, 2021

Type 2 Diabetes Trial (Omarigliptin, Placebo to omarigliptin, Glipizide)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • (no location specified)
Aug 8, 2018

Type 2 Diabetes Trial in China (Dapagliflozin, Acarbose)

Terminated
  • Type 2 Diabetes Mellitus
  • Beijing, China
  • +19 more
Nov 23, 2021

Heart Failure Trial

Not yet recruiting
  • Heart Failure
    • (no location specified)
    Jul 25, 2023

    Atrial Fibrillation Trial in United States (dapagliflozin, Placebo)

    Recruiting
    • Atrial Fibrillation
    • Portland, Maine
    • +4 more
    Apr 21, 2022

    Dapagliflozin Versus DPP-4 Inhibitors

    Completed
    • Type 2 Diabetes
    • Padova, Italy
      University Hospital of Padova
    Mar 9, 2020

    Type 2 Diabetes Trial (10 mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered Immediately After a Standard

    Completed
    • Type 2 Diabetes
    • 10 mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered Immediately After a Standard Breakfast.
    • +2 more
    • (no location specified)
    Mar 27, 2017

    Type 2 Diabetes Trial (Glipizide 10 mg Tablets (Geneva Pharmaceutical, Inc.), Glucotrol 10 mg Tablets (Roerig Pharmaceutical,

    Completed
    • Type 2 Diabetes
    • Glipizide 10 mg Tablets (Geneva Pharmaceutical, Inc.)
    • Glucotrol 10 mg Tablets (Roerig Pharmaceutical, Inc.)
    • (no location specified)
    Mar 27, 2017

    PreDiabetes, Obesity, Morbid, Diabetes, Type 2 Trial in Mexico City (Dapagliflozin/Metformin, Metformin)

    Unknown status
    • PreDiabetes
    • +2 more
    • Mexico City, Mexico
      Hospital de Especialidades Centro Médico Nacional Siglo XXI
    Aug 31, 2020

    Diabetes, Type 2 Trial in Curitiba (Dapagliflozin, Gliclazide MR)

    Completed
    • Diabetes Mellitus, Type 2
    • Curitiba, Parana, Brazil
      Centro de Diabetes Curitiba
    Mar 1, 2020

    Diabetes, Pulmonary Tuberculosis Trial in Bandung, Lima, Bucharest (intensive monitoring)

    Completed
    • Diabetes Mellitus
    • Pulmonary Tuberculosis
    • intensive monitoring
    • Bandung, West Java, Indonesia
    • +2 more
    Apr 17, 2019

    Diabetes, Type 2 Trial in Boston (Glipizide, Metformin, Oral Glucose Tolerance Test)

    Unknown status
    • Diabetes Mellitus, Type 2
    • Glipizide
    • +2 more
    • Boston, Massachusetts
    • +2 more
    Jan 11, 2017

    Diabetes Trial in Thessaloniki (Dapagliflozin, Placebo)

    Terminated
    • Diabetes Mellitus
    • Thessaloniki, Greece
    • +2 more
    Nov 30, 2019

    Type 2 Diabetes Trial (Sitagliptin, Comparator: Placebo, Pioglitazone)

    Completed
    Has Results
    • Type 2 Diabetes Mellitus
    • (no location specified)
    Apr 27, 2017

    Diabetes, Type II Trial (Sitagliptin (MK0431), Placebo/Glipizide 5 mg, Metformin)

    Completed
    Has Results
    • Diabetes Mellitus, Type II
    • Sitagliptin (MK0431)
    • +3 more
    • (no location specified)
    Mar 31, 2017

    s on Risk of Heart Failure Hospitalization and Amputation for

    Completed
    • Diabetes Mellitus, Type 2
    • Cardiovascular Diseases
    • Titusville, New Jersey
      Janssen Investigative Site
    Aug 24, 2018

    Incretin-based Drugs and Acute Pancreatitis

    Completed
    • Diabetes Mellitus, Type 2
    • DPP-4 inhibitors
    • +7 more
    • Montreal, Quebec, Canada
      Lady Davis Institute for Medical Research, Jewish General Hospit
    Nov 1, 2016